breast cancer
Conditions
Interventions
Observation Group:Routine symptomatic treatment combined with Huolongguan comprehensive moxibustion
Sponsors
the First Hospital of Hunan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1)Patients diagnosed with breast cancer confirmed by histopathological examination. (2)Patients accompanied by Cancer-Related Fatigue. (3)Patients currently receiving in-hospital chemotherapy, with clear consciousness, stable medical condition, and an estimated survival time of = 6 months. (4)Aged 18 to 70 years. (5)Patients (and their families) who fully understand the purpose, procedures, and risks of the study, participate voluntarily, and sign the written informed consent form.
Exclusion criteria
Exclusion criteria: (1)Patients with other concurrent primary malignancies, or those with breast cancer involving distant metastasis. (2)Patients with severe organic diseases, or poorly controlled endocrine or rheumatic immune disorders. (3)Patients with psychiatric disorders who are unable to express themselves clearly or cooperate in completing questionnaires and complying with study procedures. (4)Patients currently receiving other treatments specifically for fatigue. (5)Patients with contraindications to Huolongguan comprehensive moxibustion (e.g., skin lesions, infections, scars, or severe dermatological conditions in the treatment area).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Piper Fatigue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Questionnaire-Breast Cancer Module;Structure and composition of the gut microbiota;Immunological status;Peripheral serum inflammatory factors;Treatment adherence;Safety evaluation;TCM syndrome scores; | — |
Countries
China
Contacts
Public ContactHe Yana
the First Hospital of Hunan University of Chinese Medicine
Outcome results
None listed